latest news releases from the newsroom
Sciax Technology, Inc.
Sciax Announces Major Sale to the Canada Customs and Revenue Agency
BAY CITY, Mich. and TORONTO, Dec. 6, 2004 (PRIMEZONE) -- Sciax Corp. (Pink Sheets:SCXC) announced today that the company has received an order for Sciax Wolf Pack(tm) remote viewing systems from the Canadian Border Services Agency (CBSA). The contraband interdiction unit of CBSA (formerly Canada Customs) has been an important and successful user of the company's systems for several years.
Environmental Technologies International, Inc.
EMTI's AWE Marketing Team To Expand Horizons. . . Targeting Global Markets
TUCSON, Ariz., Dec. 6, 2004 (PRIMEZONE) -- Environmental Technologies International, Inc. (Pink Sheets:EMTI) is pleased to announce that it intends to seek out offshore distributors for its AWE building HVAC retrofit units currently being developed for mass markets. Initially, Management intends to focus on those geographical regions, both in the United States and around the globe, that must contend with the extreme indoor environmental control problems typical of tropical and/or semi-tropical climates, i.e. excessive heat and humidity that fosters building mold and mildew as well as a scarcity of high-purity, potable water in many such regions. A shortage of electrical energy, reflected in very high costs, also coincides with these indoor environmental problems in many regions of the globe.
World Golf League, Inc.
The WGL to Distribute Discount Memberships to the Golf Industry
ORLANDO, Fla., Dec. 6, 2004 (PRIMEZONE) -- The World Golf League, Inc. (OTCBB:WGFL) announced today that it has reached an agreement with Upwon, LLC to distribute up to 500,000 WGL discount memberships through public and semi-private golf courses throughout the country. This will represent over 7,500 golf courses with access to 18 million golfers. When a membership is redeemed by the golfer, the golf course will receive $15.00 while the member pays the WGL $65.00.
Maxim Pharmaceuticals Reports Data from its Phase 3 Trial of Ceplene in Acute Myeloid Leukemia Patients at American Society of Hematology Annual Meeting
SAN DIEGO, Dec. 6, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) announced today additional data from its randomized and controlled Phase 3 trial (MP-MA-0201) investigating Ceplene plus Interleukin-2 (IL-2) in the treatment of acute myeloid leukemia (AML) patients in complete remission during an oral presentation at the American Society of Hematology 46th Annual Meeting and Exposition. The data presented included the updated p-value (p=0.0096) for the primary endpoint of leukemia free survival, and details of the demographics, risk factors and other baseline characteristics of the patient population, which were all well balanced. The preliminary p-value previously reported (p=0.026) only stratified the patient population by complete remission status and did not additionally stratify by country as set forth in the study protocol.
Maxim's Senior Director of Regulatory Affairs and Drug Safety Resigns
SAN DIEGO, Dec. 6, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) announced today that Richard Lowenthal, Senior Director of Regulatory Affairs and Drug Safety at Maxim, has resigned to pursue an opportunity to be one of the first employees of an early-stage biotechnology company. Sharon Tonetta, Ph.D., Vice President of Drug Development, and Mr. Lowenthal's supervisor at Maxim, will continue to head the company's regulatory affairs and drug safety. Additionally, John F. Bedard, a member of Maxim's board of directors, has agreed to act as interim lead of regulatory affairs. Mr. Bedard, a former Vice President, FDA Liaison and Global Strategy at Bristol-Myers Squibb, has over twenty-five years of experience directing drug development and registration programs in the pharmaceutical industry. Drug Safety will be lead by Emma Barrett, M.D., Maxim's Senior Director of Medical Affairs.
Transmeridian Exploration, Inc.
TransMeridian Exploration Provides Operational Update on Website
HOUSTON, Dec. 6, 2004 (PRIMEZONE) -- TransMeridian Exploration, Inc. (OTCBB:TMXN) today announced that it will now provide investors with a ready access to routine operational information through its corporate website. This information may be accessed by clicking on "Operations Update" in the Operations area of the company's corporate website. It is expected that this site will be updated at least quarterly, but may be updated more frequently as operational developments warrant. As usual, material events will still be provided by press releases to our investors and shareholders. This change should provide investors another means of staying abreast of our operations.
Australian-Canadian Oil Royalties Ltd.
Longtom-2 DST No. 1 Confirms 18-19 MMCF Per Day Under Australian-Canadian Oil Royalties ORRI VIC/P54
CISCO, Texas, Dec. 6, 2004 (PRIMEZONE) -- Australian-Canadian Oil Royalties Ltd. (OTCBB:AUCAF) is excited to announce that Apache Corp. has reported the results of the first Drill-stem test (DST) on the Longtom-2 well in the offshore Gippsland Basin of Victoria in the Bass Strait. The Longtom-2 well flowed at a stabilized rate of 18-19 MMCF/per day of gas through a 1" choke over an 11 hour period with well head pressure at the end of the test at approximately 965 psi. The Longtom-2 well was tested over the interval 2184.0-2192.5 meters and 2212.5-2243.5 meters. This interval will be isolated and the well prepared for DST No. 2. The well also flowed gas with a Condensate to Gas Ratio of approximately 3 barrels/MMCF. VIC/P54 covers 155,676 gross acres and ACOR has a .05% ORRI under all this acreage. We are pleased to report this new discovery.